Synucleinopathy: Clinical Trials

4 trials for Synucleinopathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting, 2 recruiting. 2 Phase 2, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 22Active not recruiting 1, Recruiting 1
Not applicable1Active not recruiting 1

Follow Synucleinopathy: new trials by email Literature Review of Synucleinopathy trials Research Report on Synucleinopathy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tenapanor in Synucleinopathy-Related Constipation
Tenapanor, Placebo - Synucleinopathy, Parkinson's Disease
Phase 2RecruitingCedar Valley Digestive Health Center302025-01-012025-02-10
Toward Molecular Profiling of Parkinson's Disease in Easily Accessible Biological Matrices
biomarkers - Parkinson Disease, Synucleinopathy
Not applicableActive not recruitingAzienda Ospedaliera di Perugia3402023-05-202026-03-18
The Swedish BioFINDER Sleep Study
Dopamine transporter PET scan with [18F]FE-PE2I, Magnetic resonance imaging (MRI), [123I] MIBG scintigraphy of the heart - Parkinson“s Disease, REM Sleep Behavior Disorder (iRBD)
RecruitingSkane University Hospital6502021-10-012026-04-16
A Clinical Study of the Efficacy of Idebenone in the Treatment of iRBD Into Synucleinopathies
Idebenone, Placebo - Rapid Eye Movement Sleep Behavior Disorder, Synucleinopathy
Phase 2Active not recruitingRuijin Hospital282020-08-312025-11-25

Narrower conditions

Synucleinopathies (4)  ·  Parkinson Disease (3)  ·  REM Sleep Behavior Disorder (2)  ·  Alzheimer Disease (1)  ·  Constipation (1)  ·  Disease (1)  ·  Lewy Body Disease (1)  ·  Parkinson Disease 4, Autosomal Dominant Lewy Body (1)

Broader conditions

Metabolic Diseases (4)  ·  Nervous System Diseases (4)  ·  Neurodegenerative Diseases (4)  ·  Nutritional and Metabolic Diseases (4)  ·  Proteostasis Deficiencies (4)  ·  Basal Ganglia Diseases (3)  ·  Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Mental Disorders (3)  ·  Movement Disorders (3)  ·  Parkinsonian Disorders (3)  ·  Dementia (2)  ·  Neurocognitive Disorders (2)  ·  Parasomnias (2)  ·  Pathological Conditions, Signs and Symptoms (2)

Interventions

Environmental Biomarkers (1)  ·  Magnetic Resonance Imaging (1)  ·  Polysomnography (1)  ·  idebenone (1)  ·  tenapanor (1)

Sponsors

Azienda Ospedaliera di Perugia (1)  ·  Cedar Valley Digestive Health Center (1)  ·  Ruijin Hospital (1)  ·  Skane University Hospital (1)

Countries

China (1)  ·  Italy (1)  ·  Sweden (1)  ·  United States (1)

Top investigators

Erik Stomrud, MD, PhD (1)  ·  Harichandana Punukula, PharmD, MS (1)  ·  Lucilla Parnetti, MD, PhD (1)  ·  Ravindra Mallavarapu, MD (1)  ·  Richard A. Manfready, MD, AM, FACP (1)

Results publications

PMID 36172027